LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF7 | Erlotinib | 0.0109 |
| MCF7 | Alvocidib | 1.3181 |
| MCF7 | Foretinib | 0.7786 |
| MCF7 | Pictilisib | 0.9386 |
| MCF7 | GDC-0980 | 1.0235 |
| MCF7 | Gefitinib | -0.0264 |
| MCF7 | Geldanamycin | 0.9371 |
| MCF7 | GSK 690693 | 0.5584 |
| MCF7 | GSK1059615 | 0.5879 |
| MCF7 | GSK1904529A | 0.5971 |
| MCF7 | Omipalisib | 1.0520 |
| MCF7 | GW843682X | 0.7993 |
| MCF7 | HG-5-113-01 | 0.6503 |
| MCF7 | HG-5-88-01 | 0.6055 |
| MCF7 | HG-6-64-01 | 0.1757 |
| MCF7 | Imatinib | -0.0522 |
| MCF7 | JNK-9L | 0.8608 |
| MCF7 | JW-7-24-1 | 0.6808 |
| MCF7 | KIN001-043 | 0.2100 |
| MCF7 | Lapatinib | 0.1382 |
| MCF7 | LDN-193189 | 0.2909 |
| MCF7 | Linifanib | 0.1276 |
| MCF7 | Linsitinib | 0.4509 |
| MCF7 | Mitoxantrone | 1.1353 |
| MCF7 | MK2206 | 0.6858 |